Replies to post #264776 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I think there could be unnecessary treatment delay and/or inadequate communication to investors. If I’m wrong NWBO has nothing to fear from any possible regulatory review. Nothing. If I’m right, then patients and investors have been suffering unnecessary delay and inadequate guidance. This should be remedied.